← Back to timeline

2026-09-28CORP ACTION

Viking Therapeutics, Inc. [VKTX] - Convertible Note Issuance

Viking Therapeutics is issuing convertible notes with terms that include a condition for any change of control transactions to provide per-share consideration greater than the public offering price, although specific dollar amounts or terms are not disclosed in the filing excerpt.

View source filing ↗

Why this matters

Generating analysis…